Landos Biopharma (LABP) PT Lowered to $7 at JPMorgan
Tweet
Share
E-mailGet Alerts LABP Hot Sheet
Price: $22.06 +0.46%
Rating Summary:
1 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 11 | New: 13
Rating Summary:
1 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 11 | New: 13
Join SI Premium – FREE
JPMorgan analyst Jessica Fye lowered the price target on Landos Biopharma (NASDAQ: LABP) to $7.00 (from $15.00) while maintaining a Neutral rating.
You May Also Be Interested In
- AGNC Investment Corp (AGNC) PT Lowered to $10.25 at Jones Trading
- Murata Manufacturing Co Ltd. (6981:JP) (MRAAY) PT Raised to JPY3,600 at Nomura/Instinet
- Lotte Chemical Corp (011170:KS) PT Lowered to MYR90,000 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
